Abveris
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1250 Hancock St Ste 210N, Quincy, Massac...Phone Number
(781) 562-1170Website
www.abveris.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Abveris
Abveris is Boston's premier antibody discovery company providing contract research services to the biopharma industry. Abveris applies advanced immunization methods combined with B cell screening and hybridoma-based antibody discovery technologies to provide comprehensive gene-to-antibody discovery services. Abveris is developing the next generation of biologics, cell therapies, vaccines, and diagnostics in partnership with global biopharma leaders.Explore more
Abveris Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Abveris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Abveris has new funding data
Click to see if Abveris had a recent Job posting/layoffs
Check if Abveris has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Abveris launches new products
Abveris, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Abveris is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Abveris recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Abveris
Recommended Actions
Find VP level buyers at Abveris
Find more new buyers
Compare Similar Companies to Abveris
Compare insights from companies similar to Abveris, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Abveris is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Abveris is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Abveris.
Abveris Tech Stack
A closer look at the technologies used by Abveris
Most Recent Scoops
Event
will be attending the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo conference as an exhibitor. The event will occur from July 24 to July 28, 2022.
Left Company
Executive Move
Tracey Mullen, Chief Executive Officer, has left the organization and now serves as Senior VP, Operations at Twist Bioscience Corporation.
Mergers & Acquisitions (M&A)
Facilities Relocation / Expansion
Abveris is planning to move its offices in January 2022. The move will impact approximately 50 employees at their existing office located at 480 Neponset Street, Canton, MA.
Facilities Relocation/Expansion
Promotion
Executive Move
Executive Moves, Promotion
Abveris News & Media
Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it entered into a definitive agreement to acquire Abveris, (formally known as AbX Biologics, Inc.) a privately held in vivo antibody discovery services company developing the next generation of biologics, cell therapies, vaccines, and diagnostics in partnership with globalAbveris Announces Multi-Target, Multi-Year Therapeutic Antibody Discovery Collaboration with Prometheus Biosciences
CANTON, Mass. and SAN DIEGO, Nov. 11, 2021 /PRNewswire/ -- Abveris, a leader in antibody drug discovery, today announced that Prometheus Biosciences and Abveris have entered a multi-year collaboration to develop therapeutic antibodies against multiple targets. The partnership will expand...Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets
SAN DIEGO and CANTON, Mass., Aug. 24, 2021 /PRNewswire/ -- Abveris, Inc. ("Abveris") and Abilita Bio, Inc. ("Abilita"), both privately held biotechnology companies, announce a joint research collaboration that will leverage the synergies between their platforms to enable the discovery of...Tracey Mullen, CEO of Abveris honored by World Biz Magazine Awards with "Top 100 Innovation CEO" Award
Tracey Mullen, CEO of Abveris has been announced as a “Top 100 Innovation CEO - 2021” by World Biz Magazine. LONDON, UNITED KINGDOM, August 16, 2021 /EINPresswire.com/ -- Tracey Mullen, CEO of Abveris has been selected by the Judges of World Biz …
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Abveris
Sign Up For FreeTo access detailed company insights
Abveris is Boston's premier antibody discovery company providing contract research services to the biopharma industry. Abveris applies advanced immunization methods combined with B cell screening and hybridoma-based antibody discovery technologies to provide comprehensive gene-to-antibody discovery services. Abveris is developing the next generatio... Read More
